Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3660845 | 0.93 | DGKA (0.67) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3660743 | 0.93 | DGKA (0.67) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3658536 | 0.93 | DGKA (0.67) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3657916 | 0.93 | DGKA (0.67) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL9770163 | 0.88 | DGKA (0.75) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3655660 | 0.88 | DGKA (0.75) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3663265 | 0.88 | DGKA (0.75) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3661199 | 0.88 | DGKA (0.75) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3656150 | 0.88 | DGKA (0.75) | DGKALMNAMAPTPRSS1PRSS2 | |
| SCHEMBL3823248 | 0.87 | DGKA (0.52) | DGKALMNAMAPTPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7563901-B2 | Intermediates of 2-substituted carbapenem derivatives and process for production thereof | MEIJI SEIKA KAISHA, LTD. (JP) | 2009-07-21 | — | — | US | disclosed |
| US-7524951-B2 | Intermediates of 2-substituted carbapenem derivatives and process for production thereof | MEIJI SEIKA KAISHA, LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20090082571-A1 | Intermediates of 2-substituted carbapenem derivatives and process for production thereof | SASAKI TOSHIRO | 2009-03-26 | — | — | US | disclosed |
| US-20080167475-A1 | Intermediates of 2-substituted carbapenem derivatives and process for production thereof | SASAKI TOSHIRO | 2008-07-10 | — | — | US | disclosed |
| US-20080076917-A1 | Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-03-27 | — | — | US | disclosed |
| EP-1582522-A1 | INTERMEDIATE FOR 2-SUBSTITUTED CARBAPENEM DERIVATIVE AND PRODUCTION PROCESS | MEIJI SEIKA KAISHA LTD. (JP) | 2005-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167475-A1 | Intermediates of 2-substituted carbapenem derivatives and process for production thereof | MGAM, G6PD, COASY | DGKA 2677/4885LMNA 1956/4885MAPT 4112/4885 |
| US-20080076917-A1 | Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof | MGAM, G6PD, COASY | DGKA 2677/4885LMNA 1956/4885MAPT 4112/4885 |
| US-20090082571-A1 | Intermediates of 2-substituted carbapenem derivatives and process for production thereof | MGAM, G6PD, COASY | DGKA 2677/4885LMNA 1956/4885MAPT 4112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.